title: Regression of hepatic adenomata after cessation of selective oestrogen receptor modulator.
authors.affiliation: Department of Laparoscopic and Hepatobiliary Surgery, King's College Hospital, London, UK. kirstin.carswell@kch.nhs.uk
authors.forename: Kirstin A
authors.initials: KA
authors.lastname: Carswell
authors.forename: Ajay
authors.initials: A
authors.lastname: Belgaumkar
authors.forename: John
authors.initials: J
authors.lastname: Karani
authors.forename: Ameet G
authors.initials: AG
authors.lastname: Patel
mesh_terms: D018248:Adenoma, Liver Cell / Q000139:chemically induced* / Q000473:pathology*; D000368:Aged; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D020849:Raloxifene Hydrochloride / Q000009:adverse effects*; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects*
chemical_list: D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride